SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
155.60    2.80 (1.83%)
Bid:
155.40
Ask:
156.00
Spread: 0.60 (0.386%)
Market Cap: £890.52m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Interim Management Statement

31 Oct 2014 07:00

ELEMENTIS PLC - Interim Management Statement

ELEMENTIS PLC - Interim Management Statement

PR Newswire

London, October 30

Elementis - Interim Management Statement Elementis plc (ELM.L, "Elementis" or the "Group"), the Global SpecialtyChemicals Company, today issues its Interim Management Statement for the threemonths ended 30 September 2014. Commenting on the Group's performance Group Chief Executive, David Dutro, said: "Elementis is pleased to report another resilient performance that furtherdemonstrates our ability to deliver profitable growth in an economicenvironment that continues to be challenging. Our recent investments in newproducts and geographies combined with our strong market positions and customerrelationships mean that we have a broad base of growth opportunities. Togetherwith our ability to generate significant positive cash flow this provides anattractive platform from which to deliver sustainable value to ourshareholders." Specialty Products' sales improved by 6 per cent in both dollars and volumescompared to the same period last year. * In coatings, sales improved by 6 per cent as the business continued to benefit from its broad geographic base and recent investments in growth. North America sales improved by 5 per cent, helped by growing sales from the new decorative additives plant in New Martinsville and defoamer sales from the Hi-Mar acquisition. In Europe, sales were 11 per cent higher, or 8 per cent excluding currency, as the business team there supplemented the subdued underlying growth in Western Europe with sales of new products, as well as additional sales into Eastern Europe and the Middle East. Asia Pacific sales increased by 4 per cent and Latin America sales were similar to the previous quarter as good progress in delivering synergy benefits from the Watercryl acquisition was offset by soft underlying demand due to weak economic activity. * In personal care, sales for the quarter improved by 6 per cent, bringing the sales growth for the first nine months of the year to 16 per cent, as new products and sales into emerging markets continued to drive performance. * Sales to oil and gas drilling improved by 6 per cent as the business returned to more normal operating rates following the slower start to the year. * Operating margin in the quarter was slightly below the same period last year due to the impact of the start-up phase of the recently completed New Martinsville plant, where production activity is building in line with management expectations. Overall pricing and contribution margins across the businesses remained relatively stable. Chromium continued to perform in line with its strategy of delivering stableearnings and cash flow, with sales in the third quarter 2 per cent higher andoperating profit at a similar level to the previous period. The business hascontinued to experience solid demand in its key North American market andrecent improvements in leather tanning activity, which has been relatively softover the last two years, helped increase the percentage of sales to the regionto 68 per cent, compared to 63 per cent in the first six months of the year.Operational efficiencies continue to contribute to the overall stability andperformance of Chromium. The next planned maintenance shutdown is scheduled totake place during the first half of 2015. Strong cash flow continues to be a positive aspect of the Group's performanceand it is anticipated that the end of year balance sheet will show a net cashbalance of at least $40 million. Overall we remain confident in the Group's ability to deliver growth in excessof the underlying economies in which we operate and expect our full yearearnings per share to be in line with market expectations. END Enquiries Elementis plc Tel: +44 (0) 20 7408 9300Brian Taylorson, Finance Director FTI Consulting Tel: +44 (0) 20 3727 1000Deborah ScottMatthew Cole
Date   Source Headline
2nd Aug 20227:00 amRNSHalf-year Report
1st Aug 202211:08 amRNSTotal Voting Rights
21st Jul 20223:14 pmRNSHolding(s) in Company
1st Jul 20229:47 amRNSTotal Voting Rights
20th Jun 20221:54 pmRNSHolding(s) in Company
17th Jun 20224:35 pmRNSPrice Monitoring Extension
3rd May 202210:27 amRNSTotal Voting Rights
3rd May 20227:00 amRNSCompany Secretary Change
26th Apr 202212:28 pmRNSResult of AGM
26th Apr 20227:00 amRNSAGM Trading Statement
5th Apr 20224:17 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:52 pmRNSAdditional Listing
22nd Mar 20224:18 pmRNSAnnual Financial Report & Notice of AGM
15th Mar 20227:53 amRNSDirectorate Change
8th Mar 202212:18 pmRNSDirector/PDMR Shareholding
8th Mar 202212:17 pmRNSDirector/PDMR Shareholding
8th Mar 202211:47 amRNSHolding(s) in Company
8th Mar 202210:43 amRNSDirector/PDMR Shareholding
8th Mar 202210:39 amRNSDirector/PDMR Shareholding
7th Mar 20223:26 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPreliminary results year ended 31 December 2021
1st Mar 20222:03 pmRNSDirector Declaration
1st Mar 202211:18 amRNSBlock listing Interim Review
18th Jan 20227:00 amRNSTrading Update
10th Jan 20221:20 pmRNSHolding(s) in Company
4th Jan 202211:48 amRNSTotal Voting Rights
1st Dec 202111:10 amRNSTotal Voting Rights
10th Nov 202112:20 pmRNSHolding(s) in Company
3rd Nov 202111:25 amRNSHolding(s) in Company
1st Nov 20211:44 pmRNSTotal Voting Rights
28th Oct 20217:00 amRNSQ3 Trading Update
19th Oct 20216:10 pmRNSDirector Declaration
5th Oct 20218:42 amRNSDirector Declaration
1st Sep 20219:49 amRNSBlock listing Interim Review
2nd Aug 202110:22 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSDirectorate Change
29th Jul 20217:00 amRNSHalf-year Report
5th Jul 202110:15 amRNSTotal Voting Rights
25th Jun 20212:59 pmRNSHolding(s) in Company
23rd Jun 20212:56 pmRNSDirector Declaration
1st Jun 202110:06 amRNSTotal Voting Rights
13th May 20213:39 pmRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Statement
22nd Apr 20213:26 pmRNSAdditional Listing
20th Apr 20214:18 pmRNSResponse to Innospec Inc. announcement
20th Apr 20212:36 pmRNSPress Speculation Re Possible Offer for Elementis
9th Apr 20215:15 pmRNSAnnual Financial Report
7th Apr 20215:31 pmRNSDirector/PDMR Shareholding
1st Apr 20218:49 amRNSDirector/PDMR Shareholding
30th Mar 20214:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.